Vector Biopharma kicks of with CHF30m Series A financing
The company's patent-pending Shielded Redirected Adenoviral (SHREAD ) platform, developed by antibody grandmaster Prof. Dr. Andreas Plückthun’s...
Emergence Therapeutics licences Synaffix platform
Under the terms of the agreement, Dutch Synaffix will be eligible to receive up to $360m in upfront and milestone payments plus royalties on...
Cancer: Western life style is a killer
According to the study, Life-style related cancers are more common in richer countries. The five regions with the highest cancer death rates due to...
Pleco Therapeutics raises €17.3m in Series A
The oversubscribed investment into the Nijmegen-based specialist of modulators of the cancer micro-environment include €3.6m from Oost NL and other...
Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac
Aurobac Therapeutics SAS goal is to create next-generation antimicrobials and diagnostics to fight Antimicrobial Resistance (AMR). Decades ago, drug...
Moderna launches patent dispute with BioNTech/Pfizer
The lawsuit, filed in Boston and Düsseldorf by Moderna's general counsel Shannon Thyme Klinger and now disclosed by the U.S. company, follows a...
Kinarus announces CHF 20 million convertible bond issue
The investor, YA II PN, Ltd (Cayman Islands), is a tax vehicle of Yorkville Advisors Global LP. Under the terms of the agreement, Yorkville agrees...